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Experiments on the probable virus nature of the encephalitis preva- 
lent in  St. Louis during the summer of  1933  have been reported by 
Muckenfuss,  Armstrong,  and  McCordock  (1),  and  by Webster  and 
Fite (2, 3).  The former workers obtained a virus by inoculating brain 
tissue  from fatal  cases  into  Macacus  rhesus  monkeys;  the  latter  re- 
covered a  similar  virus  by  inoculating  the  brain  tissue  into  special 
mice.  A further step in establishing this virus as the specific cause of 
the  epidemic was the demonstration by Webster  and Fite of the in- 
activation of the virus by human convalescent sera (4).  This finding, 
confirmed by Wooley and  Armstrong  (5),  and  Muckenfuss  (6),  will 
now be described in detail. 
Technique 
The effect of serum on the virus was studied by means of the familiar protection 
test.  Virus in suitable dilution was mixed with equal volumes of undiluted serum 
and injected intracerebrally into mice.  The survival time of the injected animals 
was taken as a measure of the protective action of the sera. 
Strain 3 virus (2, 3) was used in all experiments since it proved similar to other 
strains in every respect tested.  Brains from one or two mice prostrate 3 to 5 
days following an intracerebral injection of mouse  brain  virus, were  triturated 
with alundum, diluted one part by weight of brain virus to 50 parts by volume of 
hormone broth, pH 8.0, centrifuged 10 minutes at 1,000 Ra,.*t., and the supema- 
rant made up further in serial tenfold dilutions with hormone broth.  0.3 cc. of 
each chosen dilution of the brain virus was mixed thoroughly with 0.3 co. of serum 
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in a  test tube.  The preparations were incubated 2 hours at 37°C.,  left at room 
temperature 2 hours, and then each taken up in a 0.25 ce. tuberculin syringe with 
0.25  inch 26 gauge needle and injected intracerebrally in 0.03  cc.  amounts into 
four  to  six  mice  lightly  anesthetized.  Precautions  for asepsis  were  observed 
throughout.  The condition and survival time of the injected mice were recorded 
for 21 days. 
The choice of mice proved a significant factor in maintaining a maximum and 
similar degree of infectivity of the virus and in reducing irregularities in survival 
time  of mice  within  and  between  tests.  The  unselected  Rockefeller Institute 
stock mice  (2)  maintained  the intracerebral  infectivity of the virus at varying 
levels between 3 x 10  -e and 3 x 10 -a gin. of infected mouse brain and gave irregular 
survival times.  Selected Rockefeller Institute resistant  (virus-susceptible mice) 
(2) and selected Swiss mice proved the animals of choice, since they maintained 
the infectivity of the virus at about 3 x  10  -9 gm. of infected mouse brain and 
proved most uniform in their response to the virus.  All mice were free of inter- 
current  infection and  came from our own breeding stocks.  They were  4  to  6 
weeks old and weighed 18 to 22 gin.  When, on rare occasions, a doubt arose as 
to whether an injected animal died of encephalitis, brain sections were taken and 
tissue passed to another animal to establish the diagnosis.  To test the uniformity 
of the mice, four to six were injected with each virus-serum mixture.  To test the 
infectivity of the virus in each experiment, virus plus non-contact serum mixtures 
were injected into mice in dilutions of 10 -s to  10 -~ inclusive. 
Tests were made as soon as possible after withdrawal of blood, since protective 
bodies against this virus were found to decrease in quantity with in vitro age of 
serum  (3).  Protective sera diluted  beyond 1 to  10 failed to react; hence tests 
were made at  a  final serum  concentration of  1 to  2.  Uncontrolled variations 
between experiments were checked by testing a greater part of the unknown sera 
at least twice, the non-contact control sera three to nine times, the doubtful sera 
two to four times, and some of the protecting sera two to eight times.' 
The test as now standardized is made with one non-contact and one known 
protecting serum as controls, together with five to fifteen test sera.  The control 
sera are prepared  to give virus dilutions of 10 -~ to 10 -~ inclusive, and the test 
sera to give virus dilutions of 10 -~ and 10 -6.  Each dilution of virus-serum mix- 
ture is injected intracerebrally into four Swiss mice. 
Standardization of Protection Tes~ 
The first few protection tests were devoted primarily to standardiza- 
tion of the technique  including the proper manipulation  and dilution 
of the virus, determinations  of stability of infectivity of the virus and 
of protective activity of a  given serum, variations in effect of different 
normal  non-contact  sera,  and  variability  of  results  between  tests. 
The protocol of Test  3, for example,  published  elsewhere  (7),  besides L.  T.  WEBSTER,  G.  L.  I~ITE~ AND  A.  D.  CLOW  829 
demonstrating the protective effect of St. Louis convalescent sera, is 
an instance in which the titre of the virus was limited to the 10 -4 dilu- 
tion  by  the  technique  employed.  Following  these  early  tests,  the 
titre of virus has  remained uniform at  the  10 -7 dilution.  Again,  it 
was learned that the protective titre of the human convalescent  sera 
decreased  with i~ vitro  aging in  the  same  manner  as in  the  case of 
hyperimmune monkey sera (3). 
While  this  standardization  of procedure  was  being  accomplished, 
it appeared that certain sera protected the injected mice fully against 
100 killing doses of virus, but that others protected to a considerably 
less degree.  What, then, was to be the basis of evaluating the protec- 
tive effect of unknown sera? 
The problem,  a statistical one, was studied by Dr. H. Muench, of 
the International Health Division of the Rockefeller Foundation, and 
the results are given  below.  The  data comprised two to nine titra- 
tions on each of thirteen normal non-contact sera, and one to six titra- 
tions on each of 267 unknown sera.  Of these,  184 were classed later 
as non-protective  and 67  as protective. 
NOTE ON EVALUATION OF RESULTS OF MOUSE TESTS OF 
ENCEPHALITIS SERA 
In attempting to establish criteria for distinguishing  positive (protecting) from 
negative (non-protecting) sera, the first procedure was to find out what happens 
to "unprotected" mice that receive virus.  For this purpose there was available 
a set of test results on a series of known normal, non-contact sera which had been 
used repeatedly as controls for test runs. 
It became apparent that conditions in the first six test runs were widely diver- 
gent from those in the seventh and following.  The latter group was very uniform. 
For this reason all findings have been based entirely on the analysis of tests after 
the  sixth run.  The results in the  normal non-contact serum group  are  sum- 
marized in Table I. 
Mortality rates are not well determined by one or two deaths even in a group 
of about 150, so that the rates at 10  -4 and 10  -s cannot be regarded as very definite. 
The mortality at 10 .6 is based on only forty-seven mice and therefore it is quite 
unreliable.  The factors most certain, at least for the first two dilutions, are the 
average time of death after inoculation and its standard deviation. 
The tests were done as routine on groups of four or of six mice.  Now the 
standard deviation of the mean time of death in a  sample of six mice at  10  -4 
would be 0.7810/v'- or 0.3188 days from the mean value of the total.  In other 
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above the expected and this would occur accidentally in unprotected mice only 
some twenty-three times in 1000.  Likewise, a  mean time of death of 6.33  days 
would exceed the expected by three times the standard deviation; this could be 
accidental only thirteen times in 10,000. 
For 10 -s dilutions and for four-mouse groups, the appropriate values are used. 
In this way it is possible to arrive at the criteria given in Table II.  Here the 
+  value corresponds to twice the standard deviation above the average; +  +  is 
three times.  Values as large as the latter or larger are almost certainly not due 
to chance and the corresponding sera cannot be called "negative." 
This provides a  criterion of what is not a  negative serum.  The question of 
what cannot be positive is still to be answered: it is not known whether positive 
TABLE  I 
Virus  dilution  No.  o[  mice  No.  dying  Mortality rate 
Day of death 
Average  Standard 
(mean)  deviation 
10  -4  148  147  0. 9932  5. 3537  0. 7810 
10  -6  146  144  0.9863  5.9514  0.9953 
10  "~  47  37  0. 7872  6. 7027  0. 8339 
TABLE  II 
Average Survi~l  Time in Days 
4 mice  6 mice 
Dilution 
+  -k+  +  ++ 
10  4  6.13  6.53  6.01  6.33 
10  -5  6.95  7.44  6.76  7.17 
sera behave so differently that the average time of death is necessarily longer than 
in the case of negatives. 
This cannot be answered from a  study of known negative sera.  It would be 
difficult to establish the distribution of longevity among "protected" mice from 
the results of tests of unknown sera, since these are evidently a mixture of positive 
and  negative.  A  criterion based on  mortality rates might be  more  definite if 
mortalities in protected and unprotected mice are sufficiently distinct and  can 
be closely evaluated.  In addition, such a  criterion would be simpler and easier 
to apply than one based on length of life. 
The problem then is to evaluate the two different mortalities at different virus 
dilutions and to find the point at which there will be the sharpest difference be- 
tween them.  Here there should be the least overlapping of criteria with conse- 
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In essence this is a study of binomial distributions.  A group of tests, each test 
comprising the same number of mice among which there is a constant mortality 
rate would, in the long run, be distributed in a  perfectly stable pattern.  For 
example, 1000 groups of six mice each, with a mouse mortality of 0.9, would have 
the following most probable distribution: 
6 deaths ....................................................  532 
5  "  . ..................................................  354 
4  "  . ..................................................  98 
3  "  . ..................................................  15 
2  "  .  ..................................................  1 
while if the mortality were 0.2 we should expect: 
5 deaths ....................................................  2 
4  "  ...................................................  15 
3  "  . ..................................................  82 
2  "  . ..................................................  246 
1 death ....................................................  393 
0 deaths ....................................................  262 
As a  starting point, we may assume that the distribution of test results (by 
number of mice dying) of any group of unknown sera is made up of a mixture of 
two  such single distributions.  One would be  the  scatter produced by a  high 
mortality in unprotected mice which receive normal serum, which would have 
a  peak at high numbers of deaths.  The other, composed of test results in pro- 
tected mice, would have a peak at a lower mortality.  There are three unknown 
factors to be found: (a) the mortality rate of the unprotected group (=  negative 
sera); (b) the mortality of the other group (protected mice or positive sera); (c) 
the proportion of each which makes up the entire number of tests; i.e.,  the number 
of positive and of negative sera included. 
These three factors may be derived from any actual array of test results mathe- 
maticaUy in a  perfectly straightforward way.  Due to sampling variations, the 
actual distribution of a series of tests would hardly ever be exactly the expected 
one.  For this reason the values we get for the factors are the best values, meaning 
those which will give the closest  approximation .to the series we are dealing with 
since we can hardly expect absolute concurrence. 
In Table III is given, as an illustration, an actual distribution; in this case 
that of 110 tests, using four mice each, at a virus dilution of 10  -~.  A survivor is 
a mouse alive on the 21st day after inoculation, when it was dropped from obser- 
vation.  Just below the actual number of  tests in each mortality group is the 
hypothetical number calculated on the basis of the three factors obtained from 
the actual distribution.  It will be seen that the correspondence is very close; 
the main difference is that there are actually rather more two-death  results than 
might be expected. 
If the calculated mortality rates are accurate, it would be expected that any 
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third factor (distribution of positives and negatives) would vary from group to 
group depending on how many positive sera happened to be included in each. 
As a matter of fact, the unprotected mortality is very constant.  This is illus- 
trated in Table IV which summarizes the values obtained by analyzing different 
sets of data.  Four-mouse and six-mouse groups must be separated for study on 
a  binomial basis.  The two different strains of mice were also kept separate in 
TABLE  HI 
Results of Four-Mouse Tests at 10  -5 (Swiss Mice) 
No. of tests (actual) ....................  J 67.0  J 10.0  7.0  9.0  17.0  110.0 
......  (calculated) ................  166.5  I 12.2  [  3.7  ] 11.11  16.5  ]  110.0 
Calculated rates on basis of: 0.9571  mortality in 79 negative tests. 
0.1455  "  "  31 positive  " 
TABLE  IV 
Mortality Rates Derived from Test Results on "Unknown"  Sera 
Dilution 
10-~: 6 mice 
4 mice 
10-~: 6 mice 
4 mice 
10-6:4 mice 
Mouse strain 
VS 
Swiss 
VS 
Swiss 
VS 
Swiss 
VS 
Swiss 
VS 
Swiss 
No. of tests  i 
33 
95 
27 
99 
43 
92 
27 
110 
27 
67 
Calculated mortality rates 
"Protected"  "Unprotected" 
0.6504  1.0 
0.4485  0.9943 
0.1382  0.9841 
0.6954  1.0 
0.1712  0.9717 
0.2800  0.9760 
0.0639  0.9463 
0.1455  0.9571 
0.0739  0.9186 
0.1076  0.9153 
"UnI~rotected" 
rates from 
normal sera 
(Table I) 
0.9932 
0.9863 
O. 7872 
case there should be a  difference in their reactions.  Known normal sera were 
excluded. 
Not only are the unprotected mortalities homogeneous within a given dilution; 
they agree quite well with the mortality rates in known normal sera as given in 
Table I.  The average values of 0.9640 at virus dilutions of 10 -~ and 0.9160 at 
10 -6 are probably very close to the true mortalities.  This permits the statement 
that, in negative sera, the  expected occurrence of surviving mice would be as 
given in Table V.  Unprotected mortality appears to have a fixed value and the L.  T.  WEBSTER,  G.  L.  FITE,  AND  A.  D.  CLOW  833 
occurrence of five or six survivors in a  test group of six mice, for instance, would 
throw a  serum out of all reasonable probability of being negative. 
The answer to  the search for a  protected mortality is nothing like as dear. 
It appears that there is no such entity, but rather a  band of mortalities covering 
a considerable range which may reflect variations in protective power in different 
sera.  Such spreading is indicated by the wide fluctuations between the calculated 
values for different groups in the same dilution (Table IV).  The number of posi- 
tive tests in each group is comparatively small and the variations show the effects 
of sampling from a  widely spreading field.  Confirmation of this conception of 
protected mortality as a band instead of a point is found in the quite regular ex- 
cess of actual over computed results around  the  50  per cent  mortality point, 
which is shown in Table III. 
But the computed protected mortality must be a  "centering constant" of some 
sort.  That is, it must be somewhere around the middle of the band of mortalities, 
some values being higher and some lower.  In that case the lower the computed 
TABLE  V 
Expected Surdvors with Negativ  e Sera 
Dilution 
10-5:6 mice 
4  " 
10-s:  6  " 
4  ~ 
2 or more 
176 
74 
842 
378 
l  3 or more 
8 
2 
97 
23 
4 or more 
-- per 10,000 tests 
"  10,000  " 
6  "  10,000  " 
1  "  10,000  " 
value, the less spread is to be expected.  If the computed mortality is 0.5,  the 
scatter of actual values might conceivably be quite even from 0  to  1.0.  But ff 
its value is 0.1, then it cannot be an average of a series which runs heavily to high 
values. 
From this viewpoint it is possible to discuss results at different virus dilutions 
and their bearing on setting up criteria. 
Dilution 10 -4.  Negative sera produce scarcely any survivors, but the mor- 
tality among  protected mice  is so high  that  many  positive scra,  especially if 
weakly protective, will show few or no survivors and so cannot be differentiated. 
Dfluton  10 -5.  The  mortality in  negative sera is still high,  so  that  a  test 
running to three or more survivors is quite certainly positive (Table V).  Pro- 
tected mortalities are evidently at a lower level than at 10 -4, but it might be ex- 
pected that a weakly protective serum would show a  sufficient number of deaths 
to throw the results into the possibly negative category. 
Dilution  10 -e.  Although  lower,  unprotected  mortality is  still  sufficiently 
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serum.  Protected mortality now centers about a value around 0.1 or less and in 
all probability seldom is high enough to confuse protective with non-protective 
sera. 
Results at virus dilutions of 10 -6 are thus undoubtedly the most sensitive and 
delicate.  Dilutions were not carried farther than  this: at  10 -~  protected mor- 
tality would be lower but so would unprotected, and there might be less certainty 
in differentiating between  the  two  than at  10 -e.  It is  impractical to embody 
dilutions of 10 -4 in the criterion as the two mortality rates are so  nearly alike. 
As finally set up, the criterion of positive protection on the basis of mortality 
is as follows: 
TABLE  VI 
Criterion for Test Results 
No. of survivors*  ........................... 
lO-S: 6 mice 
4  " 
10-6:6  " 
4-  +  + 
+  +  [  + 
+ 
5 
+ 
+ 
6 
+ 
+ 
* At 2i days. 
A number of sera, by this criterion, are positive at 10 -6 but negative at 10 -5. 
This would  be expected in the case of weakly protective sera according to the 
interpretation of the analysis.  The  reverse result should be found very seldom 
and it has not, in fact, occurred so far.  Confirmation of the  conception of such 
positive-negative results as weak positives is seen in the fact that the same sera 
are almost invariably outside the range of possible negatives on the basis of aver- 
age length of life (Table II). 
A  q- result (Table VI) must be regarded as inconclusive unless the result at 
another dilution is clearly positive. 
The final criterion for use in practise may be established as follows: 
+  at 10 -5 and +  at 10-%  ++  (strongly positive) 
-  at 10 -5 and +  at 10-BI. 
q- at 10 -5 and  +  at 10-eJ"  +  (weakly positive) 
-  at 10 -G and 4- at 10-6:  4- (inconclusive, probably negative) 
-  at 10 -~ and  -  at 10-%  -  (negative, no  protection) 
where the +,  ±, and  -  values are determined from the number of survivors as 
given in Table VI. 
Results with Sera from Persons with No History of Exposure  to St. Louis 
Encephalitis 
Sera  were  collected  from  September,  1933,  to  date  from  healthy 
non-contacts and from cases of encephalitis and poliomyelitis mostly in L.  T.  VgEBSTER~  G.  L,  FITF-~  AND  A.  D.  CLOW  835 
hospitals in eastern and north central states, t  The cases chosen were 
believed  to  have  received  careful  clinical  study,  a  matter  of prime 
importance  in  determining  the  specificity  of  the  reaction  between 
serum and virus.  The sera from the healthy non-contacts described 
below, when mixed with virus in dilutions of 10  -~ to 10  -6 and injected 
into mice, gave mortality rates of 99 per cent, 98 per cent, and 78 per 
cent, respectively, and average survival times in days of 5.3, 5.9, and 
6.7  (Table I).  The other sera,  under similar  conditions,  gave mor- 
tality rates of 99 per cent, 96 per cent, and 91 per cent  (Table IV), 
indicating that practically all mice given these sera plus virus in dilu- 
tions as low as 10 -e die in 5 to 7 days. 
TABLE VII 
Criteria for Protective Serum 
Average survival time  No. of survivors 
Dilution of virus 
4 mice tests  6 mice tests  4 mice tests  6 mice tests 
10-~ 
10-~ 
10--6 
days 
6.53 
17441 
d~y$ 
6.33 
7.17  12 
13 
3 
3 
Healthy Ntm-Co',~twts.--Sera from thirteen adults working in medical institu- 
tions in or near New York have been tested one to eight times with negative re- 
sults  (Table VII).  Protocols of repeated tests with  three of these sera are given 
in Table VIII,  showing  the uniformity of  results subsequent  to Test  14.  In 
1  The authors are grateful for the generous cooperation of physicians and hos- 
pital authorities in calling our attention to cases of encephalitis,  collecting  and 
sending sera, and supplying clinical data.  Mentioning all these collaborators by 
name is  regarded as impractical.  Most of the sera from the cases of chronic 
encephalitis  with Parkinson sequelae were sent by Dr. David Marine, Montefiore 
Hospital, New York; Dr. C.  H.  Andrewes,  National Institute for Medical Re- 
search, London; Dr. E. A. Carmichael, National Hospital Queen Square, London; 
Drs. Josephine B. Neal and Frederick Tilney, Neurological Institute, New York; 
and Dr. M. W. Raynor, Bloomingdale Hospital, White Plains,  N.Y.  Professors 
R. Inada and K. Kakinuma sent sera from twelve cases of Japanese B encephalitis, 
and Professor I. Takaki sent sera  from  three similar  cases  plus  samples  of 
hyperimmune sera and virus A and B in glycerine.  Dr.  G. F. Kempf forwarded 
sera from cases of meningoencephalopathy  in Indianapolis. 836  ENCEPHALITIS.  IV 
TABLE  VIII 
Repeated Tests with Three Sera from Healthy Non-Contacts 
Serum 
C 
H 
Tes 
13 
14 
16 
28 
43 
45 
47 
48 
49 
5O 
51 
52 
28 
36 
39 
46 
12 
28 
33 
41 
Virus-serum dilution 
Date 
1933 
Nov. 23 
"  29 
Dee.  20 
1934 
Apr.  25 
Dec.  4 
1935 
Jan.  18 
Mar.  7 
"  12 
May  8 
"  24 
June  5 
"  10 
1934 
Apr.  25 
Oct.  10 
"  25 
"  30 
I935 
Jan.  31 
1933 
Nov. 16 
1934 
Apr.  25 
Sept. 25 
Nov. 12 
10-3 
4, 5, 6, 7 
4, 4, 4, 6 
4, 5, 5, 6 
lO-a  lO-S 
5, 5, 5, 6 
4, 5, 6, 7 
4, 5, 5, 5, 
6, 6 
5, 5, 5, 6, 
6, 6 
6, 6, 6, 6 
5, 5, 5, 6 
5, 5, 6, 6 
5, 5, 5, 5 
6, 6, 6, 6 
5, 5, 6, 6 
5, 6, 6, 6 
*, 5, 5, 6 
5, 6, 6, 6, 
6, 6 
5, 5, 5, 6, 
6, * 
4, 5, 5, 5 
4, 6, 6, 8 
5, 6, 6, 6 
5,5,6,  6 I 
6, 6, 6, 6, 
6, 7 
5, 5, 5, 5, 
5, 5 
5, 5, 5, 5 
5, 6, 6, S 
6, 6, 9, S 
5, 5, 5, 6, 
6, 6, 6, 6, 
7, 7 
6, 6, 6, 7 
6, 6, 6, 7 
6, 6, 6, 6 
5, 5, 5, 6, 
6, 7 
5, 6, 6, 7 
6, 6, 7, 7 
5, 6, 7, 7 
5, 5, 6, 6 
6, 6, 6, 8, 
8, 8 
5, 5, 5, 6, 
6,1 
4,5,  ,7 
6,6,  ,6 
5, 6, 6, 6 
51 
6, 
5, 
5, 
6, 6, 6 
6, 6, 6, 
7, 7 
5, 5, 6, 
6, 9 
5, 7, 7 
10_6 
7, 7, 7, 8 
6, 6, 7, 8 
5, 7, 7, 7 
6, 6, 7, 7, 
7, 9 
6, 6, 7, 7 
7, 7, 9, 9 
5, 6, 6, 7 
5, 6, 6, 7 
6, 6, 7, 7 
6, 7, 8, 8 
5, 5, 7, 9 
7, 7, 7, 7 
10-7 
8, S, S, S 
6, 6, 11, 12 
8, 8, S, S 
7, 8, 8, 9 
7, 8, S, S 
8, 10, S, S 
6, 6, 7, 7 
6, 7, 8, 8 
6, 8, 9, S 
7, 7, 7, 7 
S  =  mouse remained well 21 days. 
Blank spaces indicate dilution not tested. 
*  =  mouse died from trauma. L.  T.  WEBSTER~ G.  L.  I~ITE~ AND  A.  D.  CLOW  837 
contrast  to  these  findings  reported  in  1933 (4),  Wooley and  Armstrong state 
(1934)  (5) that eleven of 113 sera (9.7 per cent)  from individuals with no special 
contact with cases gave strong or moderate protection.  This discrepancy will be 
discussed  later. 
Chronic Lethargic Encephalitis with Parkinson Sequelae.--Webster and  Fite 
reported in  1933 (4)  that  sera from sixteen  cases of lethargic encephalitis  with 
Parkinson sequelae failed to protect mice against the virus.  Similar results were 
reported by Levaditi,  Schoen, and  Levaditi  (1934)  (8)  on sera from four cases. 
Wooley and Armstrong, however, state (1934)  (5) that sera of four of twenty-nine 
(13.7  per cent)  tested cases showed  strong protection. 
We have now studied a  total of twenty-seven sera from typical cases.  The 
results are negative.  Nine cases gave  a  history of onset following an attack of 
influenza in 1918  to  1920.  All  have had Parkinson sequelae  for 1 to  15 years. 
'Typical, Acute Encephalitis (Economo).--The negative effect of sera from the 
twenty-seven chronic cases of outspoken encephalitis of the Economo type raised 
the question of whether sera from the same disease in the more acute stages would 
show protective substances against the St. Louis virus.  Realizing that a  clinical 
diagnosis of this disease in the acute stages is often difficult, an effort was made 
to obtain sera from both typical and atypical cases. 
Eight  typical acute  cases were  tested  and  found to  be  negative.  All gave 
histories of lethargy, ptosis or diplopia, tremors, and mononuclear pleoeytosis of 
the spinal fluid.  Two had beginning mask facies.  Blood was drawn for testing 
2, 2, 4, 6,  10,  12,  16, and 26 weeks after onset. 
Atypical Primary Encephalitis.wSixty-nine cases of atypical primary encepha- 
litis were also tested with negative results.  Symptoms and signs varied widely 
but  were of such a  nature  in each case as  to warrant  a  clinical  impression  of 
"encephalitis."  Three  cases  occurred in  1932,  twenty-eight  in  the  autumn  of 
1933, thirty in 1934, and eight in 1935.  Sera for testing were obtained 2 to 52 
weeks after onset of illness.  Twenty-four were from New York, two from New 
Jersey, six from Connecticut, two from Massachusetts,  one from Pennsylvania, 
five from Maryland, four from Virginia, one each from Florida and Alabama, five 
from Illinois, four from Missouri, one from Indiana, eleven from Ohio, and two 
from California. 
Japanese B Encephalitis.--We found (1934)  (9) that sera from fifteen cases of 
Japanese B encephalitis did not protect against the St. Louis virus.  These results 
were surprising in view of the reported similarity in epidemiological and clinical 
features of the Japanese and St. Louis diseases  (10). 
Sera  were received from three persons  supposed  to  have  had  the disease  in 
August, 1924, aged 50, 51, and 60 years, and from nine persons convalescent from 
the August, 1933, epidemic, aged 17, 17, 20, 26, 33, 46, 53, 62, and  65 years.  In 
these eases fever subsided 6 to 12 days after onset of symptoms.  Sera were like- 
wise received from three additional persons convalescent from the 1933 epidemic. 
Blood specimens were drawn from the 1924 cases about 10 years after onset and 
from the  1934  case about  4  months  after  onset.  Specimens were  tested  after 838  ENCEPHALITIS.  IV 
about 6 weeks' aging in dtro.  Each serum was tested twice with negative results. 
Kodama has recently confirmed these findings using Strain 3 virus and serum from 
convalescents in Japan (13).  Further negative tests on sera from animals immun- 
ized with Takaki's B and A viruses (11), and futile attempts to establish the B 
virus from glycerinized material are reported below. 
Postinfectious Encephalitis.--Sera from ten cases of postinfectious encephalitis 
were tested and found negative.  Three cases were encephalitis  following herpes 
zoster; two additional cases of herpes zoster without encephalitis were found nega- 
tive. Four cases were post-measles  encephalitis,  two post-pertussis encephalitis, 
and one encephalitis  complicating varicella. 
Meningoencepkalopathy, Indianapolis.--Sera from two convalescents from men- 
ingoencephalopathy at Indianapolis described by Kempf, Gilman, and Zerfas (12) 
did not protect against the virus (4). 
Australian "X" Disease.--Serum from a case reported to have had "X" disease 
was found negative. 
Poliomyelitis, Los Angeles, 1934.--Sera from eleven cases of poliomyelitis in 
Los Angeles, 1934, were obtained 4 weeks and 8 months after onset of symptoms. 
All were negative. 
In summary, none of the  156 tested sera from persons believed to 
have had no exposure to St. Louis encephalitis has shown protective 
antibodies against the virus.  Wooley and Armstrong's series of simi- 
lar cases  (a) lethargic encephalitis,  (b) unclassified encephalitis, acute 
meningoencephalifis, epidemic meningoencephalopathy, poliomyelitis, 
traumatic  encephalitis,  postinfecfious  encephalitis,  Jacksonian  epi- 
lepsy,  (c)  other diseases not neural,  and  (d)  normal controls with no 
special contact, gave positives at the rates of 13.7 per cent of 29, 11.4 
per cent of 34,  13.1 per cent of 99,  9.7 per cent of 113, respectively, 
or 11 per cent of the total 275. 
Results with Sera from Animals Immunized with Known Viruses 
The protection test was used not only to determine the specificity 
of the reaction between serum and virus but to discover a  serological 
relationship  between  the  St,  Louis  and  other known  viruses.  Sera 
from immunized  animals  known  to  protect  against  the  homologous 
virus  * were tested against the St. Louis virus.  The results were nega- 
2 The herpes sera were supplied by Dr. Margaret Holden, and the Japanese 
encephalitis A and B sera by Professor I. Takaki.  Dr. C. TenBroeck sent us the 
equine encephalomyelitis, sera and carried out the protection tests with the en- 
cephalomyelitis  virus.  We are indebted to Dr.  P. J.  du Toit, Pretoria, South L.  T.  WEBSTER,  G.  L.  ~'ITE,  AND  A.  D.  CLOW  839 
tive, indicating no serological relation between this and the following 
viruses:  herpes,  Japanese  B  and A, poliomyelitis,  equine  encephalo- 
myelitis,  vesicular  stomatitis,  louping  ill,  blue  tongue,  and  fox  en- 
cephalitis .~ 
tterpes.--Sera  from six rabbits  immunized with the E. L. 1 Perdrau strain were 
tested with negative results. 
Japanese Encephalitis A  and B:--One specimen  each of anti-A and  anti-B 
goat serum was received  for testing.  The anti-A serum run on two occasions 
did not protect against the St. Louis virus.  The anti-B serum contained preserva- 
tive and gave some protection against  St. Louis encephalitis, louping ill, and yel- 
low fever viruses.  When injected  without virus into mice, it induced  transient 
convulsions. 
Besides sera,  specimens of virus  A and virus B were received.  One lot of B 
virus in rabbit brain preserved in glycerin was received Feb. 8, 1934, and injected 
into six white-face mice and three 800 gin. rabbits intracerebrally,  intracutane- 
ously, and intracorneally.  The animals remained  well.  Later, the material  was 
injected into three 800 gin. rabbits intracorotidly, into three subdurally, into three 
intracerebrally,  into  two  intratesticularly,  and  into two intravenously.  All re- 
mained well.  A second lot of B virus and a specimen of A virus were received May 
11, 1934, and each injected  subdurally,  intracerebrally,  intracarotidly, and intra- 
testicularly  into a total of twenty-five 800 gin. rabbits.  No virus could be demon- 
strated. 
Poliomyelitis.--Sera from two Macacus rhesus monkeys immunized by repeated 
injections of the M. V. virus did not protect against the St. Louis virus. 
Equine Encephalorayelltis.--Sera from a  rabbit  immunized  with  the western 
strain and from a  rabbit and horse immunized  with the eastern  strain were re- 
ported negative by Cox and Fite (14).  Later tests have now been made with sera 
from a guinea pig immunized to the western strain and from a horse immunized to 
the eastern strain.  These likewise showed no protective effect against the St. Louis 
virus.  Here it should also be stated that sera from monkeys immunized with the 
St. Louis virus failed to protect guinea pigs against the two strains  of encephalo- 
myelitis virus (14). 
Vesicular Stomatitis.--Serum  from a  rabbit immunized  with the New Jersey 
strain and one from a  rabbit immunized  with the Indiana strain were reported 
negative  by  Cox  and  Fire  (14).  Serum from a  monkey immunized  with  the 
St.  Louis virus  failed  to  protect  guinea  pigs  against  the  vesicular  stomatitis 
strains  (14). 
Louping IlL--Serum from a horse convalescent from an experimental  infection 
of louping ill showed no protective activity against  the virus.  In addition,  sera 
Mrica, for the louping ill and blue tongue sera, and to Dr. R. G. Green for the fox 
encephalitis  sera. 840  ENCEPHALITIS.  IV 
from four persons showing specific  protective substances against  the louping ill 
virus (15)  failed to protect against the St. Louis virus.  Finally, anti-St.  Louis 
monkey serum did not protect mice against the louping ill virus. 
Blue Tongue.--Serum  from sheep immunized with  the routine passage virus 
said to be antigenically similar to all other known strains did not protect against 
the St. Louis virus. 
Fox Encepkalitis.--Sera  from  a  normal  fox and  a  fox immunized  with  fox 
encephalitis virus were negative. 
Results with Sera from Persons with History of Exposure to the St. Louis 
Type of Encephalitis ~ 
St. Louis Cases, 1933.~Sera from thirty-six cases on the encephalitis 
wards of the St. Louis City Isolation Hospital during the epidemic in 
August and September, 1933, were obtained for study.  Eight cases 
diagnosed as not encephalitis of the prevailing type showed no protec- 
tive properties in their sera.  The remaining twenty-eight cases pre- 
sented the clinical picture characteristic of the majority of cases of the 
epidemic (10); namely, high incidence among adults  (17,  18, 22,  23, 
28, 30, 31, 33, 36, 37, 38, 40, 49, 49, 50, 53, 55, 55, 60, 62, 64, 68, 75, and 
75 years), systemic reactions including fever, headache, and vomiting, 
stiff neck and tongue tremors, and a lymphoid cell pleocytosis of spinal 
fluid.  82.5  per cent of the twenty-eight cases showed protective prop- 
erties against the virus (Table IX).  The negative cases were aged 23, 
36, 40, 49, and 75 years.  If the cases are grouped according to whether 
the first bleeding was made before or after the 14th day from onset, 
the seventeen sera drawn on the 14th day or later all protect, while of 
the eleven drawn less than 14 days from onset, only six, 54.5 per cent 
protect. 
The negative effect of the  "early" sera is not  understood.  The 
a Sera from St.  Louis cases of encephalitis,  1933,  were obtained through the 
courtesy of Drs. R. S. Muckenfuss, J. Eschenbrenner, Jr., and S. Weisman.  Dr. 
P. F. Stookey sent us sera from cases of encephalitis of the St. Louis and other 
types occurring in Kansas  City, and brain tissue from fatal cases.  Dr.  H.  D. 
McIntyre forwarded sera from sixteen  cases of encephalitis  in Cincinnati,  1933 
and 1934.  Sera from five cases of encephalitis in Paris,  1932, were sent by Dr. 
W. E. Conklin; later, sera from fifty cases of encephalitis of the St. Louis type in 
Paris, Danville, and Canton, Illinois, were sent by Dr. W. H. Tucker through the 
courtesy of Dr. F. J. Jirka.  The Indiana State Board of Health kindly supplied 
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view was taken in an earlier report that insufficient time had elapsed 
for the development of antibodies (4), but this is now untenable since 
second bleedings from these same cases 4 months after onset likewise 
gave negative results.  Such explanations as inability of certain per- 
sons  to  elaborate  demonstrable  antibodies  or  incorrect  diagnoses 
TABLE  IX 
Sera  Tested against Encephalitis  Virus (St. Louis Type) 
Diagnosis 
Healthy non-contacts. 
Chronic encephalitis Economo.. 
Acute  "  " 
Atypical, suspected encephaliiJs .... 
Japanese B  encephalitis.. 
Postinfectious encephalitis .... 
Meningoencephalopathy, Indianapolis ..... 
Australian "X" disease  .... 
Poliomyelitis, Los Angeles, 1934. 
Immunized animals. 
St. Louis not encephalitis, 1933... 
"  "  encephalitis, 1933. 
Kansas City encephalitis, 1933.. 
Cincinnati  "  1933. 
New York  "  1933. 
Paris, Ill.  "  1932. 
"  "  "  1934. 
Danville, Ill.  "  1934. 
Canton, Ill.  "  1934. 
Indiana  "  1934. 
Cincinnati  "  1934. 
California  "  1934 .... 
No. tested 
13 
27 
8 
69 
15 
10 
2 
1 
11 
21 
8 
28 
4 
1 
2 
12 
9 
21 
6 
5 
4 
3 
Per cent  No. positive  positive 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
23  82.5 
3  75.0 
1  100.0 
2  100.0 
11  91.6 
6  66.6 
14  66.6 
3  50.0 
5  100.0 
2  50.0 
1  33.3 
appear most probable,  even though the negative reactors were con- 
centrated in the less than 14 day group. 
These results are not in complete agreement with those of Mucken- 
fuss (6).  Fifteen of the thirty-four sera were tested by both workers 
with agreement in the case of eleven and in the case of four, positive 
results by Muckenfuss and negative by ourselves, a  disagreement of 
26.6 per cent.  We tested two of the disputed sera three times on two 
specimens; the other two, once only. 842  ENCEPHALITIS.  IV 
Kansas City Cases, 1933.--Encephalitis, so conspicuous in St. Louis 
during August and September,  1933, was present at the same time in 
Kansas City.  Here, however, fewer cases were recorded and the clini- 
cal pictures were more varied.  From one of two tested fatal cases, a 
virus was recovered similar  to  that  obtained  from fatal  cases in  St. 
Louis  (2).  At  the  same  time  sera  from four  outspoken  cases  were 
tested against the St. Louis virus and three found positive (4). 
Ohio Case, 1933.--A  white  male,  aged 41,  contracted  encephalitis 
August  30,  in  Cincinnati,  of a  type similar to  the  St.  Louis disease. 
His serum, collected and tested 1 year later, October, 1934, neutralized 
the  virus. 
New York Cases, 1933.--Recognition of cases of the St. Louis type 
of encephalitis naturally became more difficult in places remote from 
the epidemic.  Tests were made, therefore, on sera from various forms 
of atypical encephalitis,  sixteen in all, from September to the  end of 
December,  1933.  Of  these,  only  two  were  considered  clinically  as 
possible cases of the St. Louis disease. 
No. 47.  M.S., a white male, aged 27, was admitted to St. Luke's Hospital, 
Dr. FrisseU's service, on Sept. 9, 1933, with a 3 day history of nausea, vomiting, 
fever, malaise, generalized throbbing headache, and no history of having been to 
St. Louis or having come in contact with anyone from St. Louis.  On admission 
his temperature was 101°F.  There was a slight leucocytosis,  10,900, 80 per cent 
polymorphonuclears.  The Wassermann reaction was negative.  The other find- 
ings were chiefly neurological  and consisted of absent abdominal reflexes, hyper- 
active tendon reflexes, medium coarse nystagmus, soreness but no stiffness of neck, 
a suggestive Kernig, and weakness of flexion of right arm.  Spinal fluid, pressure 
240;  cells  144  (lymphoid cells  96  per cent),  globulin  +,  protein 82,  sugar  58. 
Within a  week's time all symptoms and signs had returned to normal, save for 
hyperactivity of tendon reflexes and persistence of nystagmus.  The cell count 
of the spinal fluid had dropped to 50 in 3 weeks, and to 15 in 6 weeks. 
Dr. Frissell  called  this case to our attention as possible  St. Louis encephalitis 
and tests on sera drawn 2 and 6 months after onset, ten in all, were strongly posi- 
tive (4),  (Table X). 
No. 63.  B., a white female, aged 39.  After 3 weeks' vacation in Kentucky, 
returned to New York with severe headache.  She was seen by Dr. H. T. Chicker- 
ing on Sept.  12,  1933.  Her temperature was 103°F.  She complained of severe 
headache, different from any other, accompanied by chills.  This condition cleared 
up rapidly and she was discharged as well on Sept. 25. 
Dr.  Chickering mentioned  this  case  as possible mild encephalitis of  the  St. 
Louis type.  Two tests on serum drawn 11 weeks after onset were positive (4), 
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Paris, Illinois, Cases, 1932.~In  searching for a possible relationship 
between  the  1933  St.  Louis  and  previous  outbreaks  of encephalitis, 
mention  has been made of protection  tests run  on sera from cases of 
Economo  encephalitis  with  onset  following  influenza  in  1918,  and 
meningoencephalopathy  in Indianapolis.  The results were negative. 
The  case  of  the  outbreak  of  encephalitis  in  Paris,  Illinois,  in  1932, 
however,  was  different.  Encephalitis  appeared  in  Paris,  Illinois,  a 
TABLE  X 
Positive Protection of Sera from New York, 1933, Cases against the St. Louis  Virus 
lOiS 
6, 7, S, S 
4, 4, 4, 6 
5, 6, 7, 7 
4, 5, 5, 6 
5, 6, 6, 7 
5, 5, 5, 7 
Virus-serum  dilution 
10-4  10-5 
6, S, S, S  S, S, S, S 
5, 5, 5, 5  5, 5, 6, 6 
7, 7, 9, 10  S, S, S, S 
5~ 5, 6, 6  5, 6, 6, 6 
6, 7, 7, 7  S, S, S, S 
5, 5, 6, 8  5, 5, 6, 6 
10-t 
S, S, S, S 
6, 6, 7, 9 
S, S, S, S 
5, 5, 7, 9 
S, S, S, S 
6, 7, 9, 10 
Diagnosis 
Acute  enceph- 
alitis  (St. 
Louis?) 
Chronic enceph- 
alitis (Park- 
inson) 
Acute  enceph- 
alitis  (St. 
Louis?) 
Normal  non- 
contact 
Acute  enceph- 
alitis  (St. 
Louis?) 
Chronic enceph- 
alitis (Park- 
inson) 
S  ~- mice remained well 21 days. 
community of about 9000 persons, in July and August,  1932  (16,  10). 
Twenty-seven  persons  were affected,  aged  33  to 80,  with  only three 
under 50.  The mortality  was close to 50 per cent, but convalescents 
were relatively free of sequelae.  The outstanding symptoms recorded 
were headache,  fever, nausea and vomiting,  diplopia,  and delirium or 
stupor.  Facies  were  set,  neck  rigid,  and  tongue  tremorous.  Sera 
from  five  convalescents  drawn  15  months  after  onset  were  tested 
against  the St. Louis virus.  Four of the five gave definite protection 
(4),  (Table XI).  Later,  February,  1935, 2] years after the outbreak, 844  ENCEPHALITIS.  IV 
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additional sera were obtained from ten of the cases, including three 
of the five previously tested.  Nine of the ten or eleven of the total 
twelve (91.6 per cent) were positive  (Table XI).  Wooley and Arm- 
strong found ten of eleven (90.9 per cent) positive (5). 
Illinois, Ohio, and Indiana Cases, 1934.--The reappearance  of en- 
cephalitis  in  the  north  central  states  during  the  summer  of  1934 
afforded another opportunity  to  study the  specificity of the  serum 
reaction.  Cases clinically resembling the St. Louis type were occur- 
ring in localized outbreaks  in  Illinois and sporadically in Ohio  and 
Indiana. 
Paris, IUinois.--Nine convalescents, aged 10, 15, 33, 35, 38, 44, 68, 70, and 76 
years, were bled 5 to 6 months after onset of symptoms and their sera tested against 
the St. Louis virus.  Six of the nine specimens, 66.6 per cent, gave definite pro- 
tection.  The negative cases were aged 10, 38, and 70 years.  If the 10 year old 
case is omitted, the percentage of positives becomes 75. 
Danville, Illinois.--Twenty-one convalescents, aged 9,  10, 15, 16, 19, 20, 22, 
26, 26, 27, 30, 30, 31,31,32, 33, 36, 38, 40, 59, and 60 years respectively, were tested 
2 months after onset of symptoms.  Fourteen of the twenty-one, 66.6 per cent, 
showed protective properties  in their sera.  The negative cases were aged 9, 10, 
15, 16, 22, 38, and 40 years respectively.  If the four cases aged 16 years or less 
are omitted in the count, the ratio of positive reactors is increased to fourteen of 
seventeen, or 82.5 per cent. 
Canton, IUlnois.--Sera were obtained from six convalescents aged 7,  12, 51, 
58, 75, and 80 years.  Those aged 58, 75, and 80 years protected (50 per cent). 
If the 7 and 12 year cases are omitted from the count, the ratio of positives be- 
comes three of four (75 per cent). 
In  summary,  of  thirty-six  Illinois  1934  cases  tested,  seven  were 
aged 16 years or less and did not protect; of the twenty-nine remaining 
however, twenty-three (79.3 per cent) were positive. 
Indiana Cases.--Sera from five cases drawn at least 4  weeks after 
onset were tested and found to protect against the virus. 
Ohio Cases.--Sera  from  two  of  four  typical  cases  drawn  1  to  3 
months after onset neutralized the virus. 
California  Cases, 1934.--Sera  from  one  of  three  cases  protected 
against the St. Louis virus. 
DISCUSSION 
The  specificity of the  encephalitis protection  test  is  indicated by 
the present work and by reports of Wooley and Armstrong and Muck- 846  ENCEPHALITIS.  IV 
enfuss.  The  latter:workers,  however,  record  a  10  to  30  per  cent 
incidence respectively of positive  reactors  among groups of persons 
with no special exposure to the St. Louis disease.  This discrepancy is 
due either to differences in batches of sera tested, or more probably  to 
differences in technique and criteria for testing.  Our procedure  ren- 
ders it unlikely that a  negative serum would be  called  positive but 
admits the possibility of a few weakly positive sera being called nega- 
tive.  Be that  as it may, the specificity of the serum-virus reaction 
is further evidence that this virus is the specific agent responsible for 
the human disease, and finally, that the virus is different and the en- 
cephalitis in human beings is serologically distinct from others pre- 
viously described. 
Knowledge that antibodies persist for 2½ years in the blood of con- 
valescents is an aid in searching for an endemic focus and in mapping 
out the time and space spread of the virus.  Thus far, we know that 
the disease appeared in Paris, Illinois, in 1932, and was present in 1933 
and 1934 in the north central states and New York. 
CONCLUSIONS 
1.  A protection test for measuring serological protective properties 
against the encephalitis (St. Louis type) virus is described. 
2.  Normal non-contact sera and sera from persons supposed to have 
had no exposure to the disease do not protect against the virus.  82.5 
per cent of sera from tested St. Louis encephalitis convalescents and 
at least 66 per cent of sera from tested persons thought to have had 
the disease do show protective properties. 
3.  The protective activity of sera is maintained for at least 2½ years 
after  onset  of  the  disease.  In  vitro  aging  of  serum  decreases  its 
activity. 
4.  Protection tests indicate that the virus was present as early as 
1932  in Paris,  I~nois,  spread  through the  north  central  states and 
reached New York in 1933, and was again active in the north central 
states  in  1934. 
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